Related Experiment Video

Updated: Jul 5, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of

J Todd Auman1, Howard L McLeod

  • 1UNC Institute for Pharmacogenomics and Individualized Therapy, Chapel Hill, North Carolina 27599-7360, USA.

Drug Metabolism Reviews
|May 9, 2008
PubMed

Insights

Understanding cancer patients' varied responses to chemotherapy requires examining molecular factors. Pharmacogenomics helps tailor treatments by linking drug effectiveness to genetic and molecular profiles for personalized cancer care.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Chemotherapy response varies significantly among cancer patients.
  • Identifying molecular determinants of this heterogeneity is crucial for improving treatment outcomes.
  • Pharmacogenomics offers a powerful approach to understand these variations.

Purpose of the Study:

  • To review pharmacogenomics studies focused on molecular determinants of chemosensitivity.
  • To highlight the potential of pharmacogenomics in personalizing cancer chemotherapy.
  • To integrate drug responsiveness data with molecular alterations on a genome-wide scale.

Main Methods:

  • Literature review of pharmacogenomics studies.
  • Analysis of molecular determinants (DNA, RNA, protein) influencing chemosensitivity.
  • Integration of genome-wide data with drug response information.

Main Results:

  • Pharmacogenomics studies provide insights into molecular factors affecting chemotherapy efficacy.
  • These studies enable the correlation of genetic variations with drug responses.
  • Tailoring chemotherapy based on individual molecular profiles is a key outcome.

Conclusions:

  • Pharmacogenomics is essential for understanding and overcoming chemotherapy resistance.
  • Personalized cancer chemotherapy can be achieved by leveraging pharmacogenomic data.
  • Future research should continue to explore molecular determinants for optimized patient treatment.

More Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...